Major advances in psoriasis pathogenesis gave rise to development of new effective drugs for its treatment. Particularly, biologic drugs revolutionized disease management. TNF-α inhibitors represented the opening available biologic class since 2000. Thus, adverse cutaneous reactions to their use have been extensively investigated.
Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition.
Napolitano Maddalena
;Balato Nicola;
2019-01-01
Abstract
Major advances in psoriasis pathogenesis gave rise to development of new effective drugs for its treatment. Particularly, biologic drugs revolutionized disease management. TNF-α inhibitors represented the opening available biologic class since 2000. Thus, adverse cutaneous reactions to their use have been extensively investigated.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
